Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

New research shows that blood donors could safely give blood more frequently than is allowed at present. At the moment in the UK men can give blood every 12 weeks, women every 16 weeks. The new research demonstrates that in certain situations and for certain donors, shortening the donation interval is a viable approach for blood services to take.

Blood donations began more than a century ago but until now there has been no research to discover how frequently donors can give blood without it affecting their health.

The study showed that, over a two-year period, allowing donors to give blood more frequently boosted the supply of blood to the NHS without having a major impact on their health.

The study, published in the Lancet, was carried out by a team from Cambridge and Oxford Universities and NHS Blood and Transplant, with funding from the National Institute for Health Research Blood and Transplant Research Unit in Donor Health and Genomics and NHS Blood and Transplant.

Read more (Radcliffe Department of Medicine website)

Similar stories

Long COVID: vaccination could reduce symptoms, new research suggests

While evidence suggests that people who are vaccinated before they get COVID are less likely to develop long COVID than unvaccinated people, the effectiveness of vaccination on existing long COVID has been less clear.

Com-COV vaccine study to research third dose booster options for 12-to-15-year-olds

Researchers running the University of Oxford-led Com-COV programme have launched a further study of COVID-19 vaccination schedules in young people aged 12 to 15 – with a focus on assessing different options for a third dose booster vaccination.

Population-scale study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination

COVID-19 vaccination is effective in most cancer patients, but the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.